Abiopharma

🔍 Feffer David (Director)

Company: Suzano S.A. (SUZ)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Sold 8,772,223 shares of Common shares (Direct)
  Date: 2026-08-19 | Code: J | equity_swap_involved: 0 | shares_owned_after: 358,840,106.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 554,210 shares of Common shares (Direct)
  Date: 2026-08-19 | Code: J | equity_swap_involved: 0 | shares_owned_after: 54,077,080.00 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: No transaction price was applicable because the reported disposition resulted from the cancellation of shares in connection with a capital reduction of Suzano Holding S.A.
• F2: The amount of 358,840,106 represents the total number of common shares of Suzano S.A. held by Suzano Holding S.A. following the cancellation of 8,772,223 common shares in connection with a capital reduction of Suzano Holding S.A. The reporting person, as a party to the shareholders' agreement of Suzano Holding S.A., continues to share voting and dispositive power over all such shares. The reporting person did not purchase or sell any shares.
• F3: The reporting person received 554,210 common shares pursuant to the shareholders' agreement of Suzano Holding S.A. The reporting person did not purchase or sell any shares.
• F4: The shares were received pursuant to the shareholders' agreement of Suzano Holding S.A. No purchase price or other consideration was paid in connection with the acquisition.